Concepedia

Million Arefayene

MA

Statistics

Publications

11

Citations

747

H-Index

11

Active since

2003

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Biogen (United States)

Indiana Cancer Consortium

Indiana University

Million Arefayene is an author at Indiana University – Purdue University Indianapolis specializing in pharmacology, medicine, and life sciences.

Publications per year

2003–2022

11

Publications

11

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

Kazuki Takada, Million Arefayene, Zeruesenay Desta et al. · Arthritis & Rheumatism · 2004 · 167 citations

, , +17

MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma

Teresa L. Tinder, Durai B. Subramani, Gargi D. Basu et al. · The Journal of Immunology · 2008 · 111 citations · Full text

, , +17

A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

Ganesh Raghu, Majd Mouded, Daniel C. Chambers et al. · American Journal of Respiratory and Critical Care Medicine · 2022 · 101 citations

, , +14

Progression of Pancreatic Adenocarcinoma Is Significantly Impeded with a Combination of Vaccine and COX-2 Inhibition

Pinku Mukherjee, Gargi D. Basu, Teresa L. Tinder et al. · The Journal of Immunology · 2009 · 95 citations · Full text

, , +17

Inhibition of Human Intestinal Wall Metabolism by Macrolide Antibiotics: Effect of Clarithromycin on Cytochrome P450 3A4/5 Activity and Expression*

Amar G. Pinto, Ying-Hong Wang, Naga Chalasani et al. · Clinical Pharmacology & Therapeutics · 2005 · 63 citations

, , +16

1–5 of 11